20 completed, 7 unknown, 2 terminated, 1 recruiting. 31 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 31 | Completed 20, Unknown 7, Terminated 2, Recruiting 1, Withdrawn 1 |
Follow Venlafaxine: new trials by email Literature Review of Venlafaxine trials Research Report on Venlafaxine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder Venlafaxine, Dosulepin - Somatic Symptom Disorder (DSM-V) | Phase 4 | Recruiting | All India Institute of Medical Sciences, Bhubaneswar | 84 | 2025-03-11 | 2025-09-24 |
| Mood Disorders in Head and Neck Cancer Patients Venlafaxine - Depressive Disorder, Head and Neck Cancer | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2024-01-05 | 2025-02-04 | |
| The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN) Venlafaxine - Major Depressive Disorder, Bipolar Affective Disorder, Currently Depressed, Moderate | Phase 4 | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 30 | 2022-03-01 | 2023-11-14 |
| Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine pharmacogenomics, pharmacogenomics & therapeutic drug monitoring, Venlafaxine - Depression | Phase 4 | Unknown | Xijing Hospital | 160 | 2019-12-01 | 2019-12-20 |
| Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse Venlafaxine, Lofexidine - Opiate Withdrawal Syndrome | Phase 4 | Completed | Zagazig University | 52 | 2019-01-01 | 2022-10-06 |
| The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea Venlafaxine, Placebo - Obstructive Sleep Apnea | Phase 4 | Completed | University of California, San Diego | 20 | 2016-03-01 | 2020-04-17 |
| Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder venlafaxine - Severe Major Depression Disorder | Phase 4 | Unknown | Zhejiang Provincial Tongde Hospital | 75 | 2015-02-01 | 2015-04-27 |
| Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine Propranolol, Venlafaxine - Vestibular Migraine | Phase 4 | Completed | Haseki Training and Research Hospital | 73 | 2014-01-01 | 2015-01-30 |
| Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression venlafaxine, fluoxetine - Major Depression | Phase 4 | Completed | Capital Medical University | 189 | 2013-03-07 | 2017-09-14 |
| Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications SSRI/SNRI - Depressive Disorder, Lactation | Phase 4 | Unknown | Centre Hospitalier Universitaire Vaudois | 500 | 2012-08-01 | 2015-07-28 |
| Algorithm Guided Treatment Strategies for Major Depressive Disorder Escitalopram, Mirtazapine, modified electroconvulsive therapy - Major Depressive Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 1080 | 2012-06-01 | 2013-01-10 |
| The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy Venlafaxine, Sertraline - Post Traumatic Stress Disorder, Depression | Phase 4 | Completed | Charlotte Sonne | 207 | 2012-04-01 | 2015-03-04 |
| Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression Venlafaxine, Fluoxetine, Citalopram - Depression, Relapsing-remitting Multiple Sclerosis | Phase 4 | Terminated | Novartis Pharmaceuticals | 54 | 2011-11-01 | 2014-09-25 |
| Effect of Duloxetine and Venlafaxine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol: A Three-phase Randomized Balanced Cross-over Study in Healthy Volunteers Placebo, Duloxetine, Venlafaxine - Healthy | Phase 4 | Completed | Turku University Hospital | 12 | 2011-10-01 | 2012-05-22 |
| Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene Paroxetine, Sertraline, Citalopram - Major Depression | Phase 4 | Unknown | HolsboerMaschmeyer NeuroChemie GmbH | 80 | 2011-09-01 | 2014-09-12 |
| Combination Treatment Study for Memory Impairment and Depression Donepezil, Placebo, Citalopram - Depression, Mild Cognitive Impairment | Phase 4 | Completed | New York State Psychiatric Institute | 86 | 2011-09-01 | 2017-10-17 |
| CBT as an Adjunct to SRIs in the Treatment of BDD Cognitive Behavioral Therapy, Venlafaxine - Body Dysmorphic Disorder | Phase 4 | Terminated | Icahn School of Medicine at Mount Sinai | 17 | 2008-09-01 | 2017-03-09 |
| Venlafaxine Augmentation in Treatment Resistant Depression Venlafaxine, Quetiapine - Depression | Phase 4 | Completed | Max-Planck-Institute of Psychiatry | 126 | 2008-04-01 | 2015-04-08 |
| Study of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal Subjects venlafaxine - Depression | Phase 4 | Completed | University of California, Los Angeles | 6 | 2008-02-01 | 2020-03-09 |
| Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression Electroconvulsive therapy, venlafaxine, Lithium - Depressive Disorder, Major | Phase 4 | Completed | Örebro County Council | 56 | 2008-01-01 | 2012-06-22 |
Showing 20 of 31. Sign in to see all of them.
Depression (13) · Depressive Disorder, Major (8) · Bipolar Disorder (5) · Depressive Disorder (3) · Alzheimer Disease (1) · Body Dysmorphic Disorders (1) · Brain Injuries, Traumatic (1) · Breast Feeding (1) · Cognitive Dysfunction (1) · Dementia (1) · Depressive Disorder, Treatment-Resistant (1) · Dysthymic Disorder (1) · Head and Neck Neoplasms (1) · Headache Disorders (1) · Lymphoma, Follicular (1)
Massachusetts General Hospital (2) · New York State Psychiatric Institute (2) · University of Pittsburgh (2) · All India Institute of Medical Sciences, Bhubaneswar (1) · Capital Medical University (1) · Centre Hospitalier Universitaire Vaudois (1) · Charlotte Sonne (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Haseki Training and Research Hospital (1) · HolsboerMaschmeyer NeuroChemie GmbH (1) · Icahn School of Medicine at Mount Sinai (1) · Max-Planck-Institute of Psychiatry (1) · National Cheng-Kung University Hospital (1) · Novartis Pharmaceuticals (1) · Shanghai Mental Health Center (1)
United States (11) · China (4) · Germany (4) · Canada (1) · Denmark (1) · Egypt (1) · Finland (1) · France (1) · India (1) · Italy (1) · Sweden (1) · Switzerland (1) · Taiwan (1) · Turkey (Türkiye) (1)
Andrea Allen, PhD (1) · Andrew Leuchter, MD (1) · Axel Nordenskjold, MD (1) · Bruce G. Pollock, MD, PhD (1) · Chantal Csajka, Prof PhD (1) · Charlotte K Sonne, MD (1) · Dan Iosifescu, MD (1) · Davangere Devanand, MD (1) · Eric Hollander, MD (1) · Florian Holsboer, MD, PHD (1) · Florian Holsboer, MD, PhD (1) · Gang Wang, M.D.,Ph.D (1) · Giandomenico Schiena, Doctor (1) · Gregory Pelton, MD (1)
PMID 18227745, PMID 18251622, PMID 19210951, PMID 19472307, PMID 19574030, PMID 23158959, PMID 23303421, PMID 23663588, PMID 24112999, PMID 24144505, PMID 24290367, PMID 24315979, PMID 24399428, PMID 26143402, PMID 26803764, PMID 26892848, PMID 27805299, PMID 27825327, PMID 28160351, PMID 29136600, PMID 29149756, PMID 30037778, PMID 30386416, PMID 31044001, PMID 32162723, PMID 32278781, PMID 34011310, PMID 37729663, PMID 37920522, PMID 38232249
2005 (1), R01AG040093 (1), R01MH043832 (1), R01MH060353 (1), R01MH061609 (1), R01MH070919 (1)